First Bruton’s Tyrosine Kinase inhibitor (BTKi) demonstrating clinical proof-of-concept in relapsing multiple sclerosis (RMS) [...]
It is with a heavy heart that IOMSN announces the passing of Nicola "Nicki" Ward-Abel. Nicki was a founding member of IOMSN via our UK [...]
Researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the disease and potentially [...]
Researchers have apparently found a way to help predict multiple sclerosis disease progression one year after an initial [...]
Researchers at Northwestern University are seeking volunteers to participate in the pilot testing of a new quality measure for [...]
